Trial Profile
A Retrospective, Single Center, Real-World Study Assessing Weight Changes in HIV-Positive Patients Switching from a Tenofovir Disoproxil Fumarate (TDF) to a Tenofovir Alafenamide Fumarate (TAF) Containing Treatment Regimen
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2018
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary) ; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Adverse reactions
- Acronyms 17-602
- 09 Oct 2018 New trial record
- 29 Sep 2018 Results published in the Infection Journal.